Chemotherapy for colorectal cancer

Journal of the Royal Society of Medicine

Volumn 93, Issue 8, 2000, Pages 416-419

  Nicum, S ^a   Midgley, R ^a   Kerr, D J ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ATROPINE; CAPECITABINE; DEXAMETHASONE; FLOXURIDINE; FLUOROPYRIMIDINE; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; METHOTREXATE; OXALIPLATIN; RALTITREXED; THYMIDYLATE SYNTHASE INHIBITOR; UFT;

ADJUVANT CHEMOTHERAPY; BONE MARROW SUPPRESSION; BRADYCARDIA; CANCER IMMUNOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; COLORECTAL CANCER; DOSE RESPONSE; DRUG MECHANISM; DRUG METABOLISM; DRUG POTENTIATION; FOOT DISEASE; GASTROINTESTINAL SYMPTOM; GENE THERAPY; HAND DISEASE; HEALTH CARE COST; HUMAN; HYPOTENSION; LIVER METASTASIS; MUCOSA INFLAMMATION; PERIPHERAL NEUROPATHY; REVIEW;

EID: 0033845811     PISSN: 01410768     EISSN: None     Source Type: Journal    
DOI: 10.1177/014107680009300807     Document Type: Review

References (21)

1. Colorectal cancer
2. Meta-analysis of randomised trials testing the biochemical modulation of 5-fluorouracil by methotrexate in metastatic colorectal cancer
3. Efficacy of intravenous continuous infusion of 5-fluorouracil compared with bolus administration in advanced colorectal cancer
4. Multicentre phase III study of 5-fluorouracil or UFT in combination with leucovorin in patients with metastatic colorectal cancer
5. A phase III trial (S014796) of Xeloda (capecitabine) in previously untreated advanced/metastatic colorectal cancer
6. Randomised comparative study of ORZEL (oral uracil/Tegafur) plus leucovorin (IV) versus parenteral 5-fluorouracil plus leucovorin in patients with metastatic colorectal cancer
7. A phase II trial of Xeloda TM (capecitabine) in previously untreated advanced/metastatic colorectal cancer
8. Re-appraisal of hepatic arterial infusion in the treatment of non-resectable liver metastases from colorectal cancer
9. Randomised study of hepatic arterial infusion and systemic versus systemic alone as adjuvant therapy after resection of hepatic metastases from colorectal cancer
10. Results of the Intergroup (Eastern Co-operative Group (ECOG) and Southwest Oncology Group (SWOG) prospective randomised study of surgery alone versus continuous hepatic arterial infusion of FudR and continuous infusion of 5-fluorouracil after hepatic resection for colorectal liver metastases
11. Preliminary results of a multicentre randomised trial comparing three chemotherapy regimens (de Gramont, Lokich, and Ralitrexed) in metastatic colorectal cancer
12. Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer
13. Weekly irinotecan, leucovorin and fluorouracils superior to daily x 5 LV/FU in patients with previously untreated metastatic colorectal cancer
14. Oxaliplatin with high dose leucovorin and 5-fluorouracil 48 hour continuous infusion in pretreated metastatic colorectal cancer
15. Levamisole and fluorouracil for adjuvant treatment of resected colon cancer
16. Adjuvant treatment of colorectal cancer
17. Comparison of fluorouracil with additional levamisole, higher-dose folinic acid, or both, as adjuvant chemotherapy for colorectal cancer: A randomised trial
18. Portal vein chemotherapy for colorectal cancer; a meta-analysis of 4000 patients in 10 studies
19. Chemotherapy for colorectal cancer
20. Randomised trial of monoclonal antibody for adjuvant treatment of resected Dukes C colorectal cancer
21. In vivo anti-tumour activity of 5-fluorouracil on human CRC cells genetically modified to express cytosine deaminase